[{"address1": "Ugland House", "address2": "PO Box 309", "city": "Grand Cayman", "zip": "KY1-1104", "country": "Cayman Islands", "phone": "848 230 7430", "website": "https://www.adlainortye.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trial to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; AN1025, an oral small molecule degrader of \u00df-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Yang  Lu", "age": 44, "title": "CEO & Chairman", "yearBorn": 1980, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kaiyang  Tang", "age": 59, "title": "President", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Xiaofeng  Ye", "title": "Interim CFO and VP of Business Development & Commercialization Strategy", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Victoria Elizabeth Demby Ph.D.", "age": 53, "title": "Senior VP & Global Head of Regulatory Affairs", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.98, "open": 2.0, "dayLow": 1.93, "dayHigh": 2.0, "regularMarketPreviousClose": 1.98, "regularMarketOpen": 2.0, "regularMarketDayLow": 1.93, "regularMarketDayHigh": 2.0, "payoutRatio": 0.0, "forwardPE": -1.191358, "volume": 8591, "regularMarketVolume": 8591, "averageVolume": 13758, "averageVolume10days": 54700, "averageDailyVolume10Day": 54700, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 71217576, "fiftyTwoWeekLow": 1.69, "fiftyTwoWeekHigh": 13.92, "priceToSalesTrailing12Months": 36.71009, "fiftyDayAverage": 2.10614, "twoHundredDayAverage": 2.34921, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 179969552, "profitMargins": 0.0, "floatShares": 52398010, "sharesOutstanding": 31236900, "sharesShort": 3074, "sharesShortPriorMonth": 4289, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0001, "heldPercentInsiders": 0.056599997, "heldPercentInstitutions": 0.00182, "shortRatio": 0.65, "shortPercentOfFloat": 0.0001, "impliedSharesOutstanding": 36900300, "bookValue": 0.691, "priceToBook": 2.7930536, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -51869000, "trailingEps": -1.62, "forwardEps": -1.62, "enterpriseToRevenue": 92.768, "enterpriseToEbitda": -3.466, "52WeekChange": -0.8483896, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 1.93, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 60909000, "totalCashPerShare": 0.55, "ebitda": -51924000, "totalDebt": 27226000, "quickRatio": 1.343, "currentRatio": 1.412, "totalRevenue": 1940000, "debtToEquity": 106.831, "revenuePerShare": 0.061, "returnOnAssets": -0.32840002, "returnOnEquity": -0.98904, "grossProfits": 1940000, "freeCashflow": -33957000, "operatingCashflow": -51819000, "revenueGrowth": 1.18, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -12.208759, "financialCurrency": "USD", "symbol": "ANL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -2.5252562, "regularMarketPrice": 1.93, "corporateActions": [], "regularMarketTime": 1746216000, "marketState": "CLOSED", "shortName": "Adlai Nortye Ltd.", "longName": "Adlai Nortye Ltd.", "regularMarketChange": -0.05000007, "exchange": "NGM", "messageBoardId": "finmb_1830112145", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1695994200000, "regularMarketDayRange": "1.93 - 2.0", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 13758, "fiftyTwoWeekLowChange": 0.23999989, "fiftyTwoWeekLowChangePercent": 0.14201176, "fiftyTwoWeekRange": "1.69 - 13.92", "fiftyTwoWeekHighChange": -11.99, "fiftyTwoWeekHighChangePercent": -0.86135054, "fiftyTwoWeekChangePercent": -84.83896, "earningsTimestamp": 1746043200, "earningsTimestampStart": 1746043200, "earningsTimestampEnd": 1746043200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.62, "epsForward": -1.62, "epsCurrentYear": -0.92, "priceEpsCurrentYear": -2.097826, "fiftyDayAverageChange": -0.17613995, "fiftyDayAverageChangePercent": -0.08363165, "twoHundredDayAverageChange": -0.41921008, "twoHundredDayAverageChangePercent": -0.17844725, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-09-29", "cryptoTradeable": false, "displayName": "Adlai Nortye", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]